SI1282402T1 - Stabilizirane vodne suspenzije za parenteralno uporabo - Google Patents

Stabilizirane vodne suspenzije za parenteralno uporabo

Info

Publication number
SI1282402T1
SI1282402T1 SI200130485T SI200130485T SI1282402T1 SI 1282402 T1 SI1282402 T1 SI 1282402T1 SI 200130485 T SI200130485 T SI 200130485T SI 200130485 T SI200130485 T SI 200130485T SI 1282402 T1 SI1282402 T1 SI 1282402T1
Authority
SI
Slovenia
Prior art keywords
aqueous suspensions
parenteral use
stabilized aqueous
stabilized
parenteral
Prior art date
Application number
SI200130485T
Other languages
English (en)
Slovenian (sl)
Inventor
Giuseppe Colombo
Alessandro Martini
Lloyd E Fox
Original Assignee
Pharmacia Italia Spa
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa, Pharmacia & Upjohn Co Llc filed Critical Pharmacia Italia Spa
Publication of SI1282402T1 publication Critical patent/SI1282402T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
SI200130485T 2000-05-15 2001-04-25 Stabilizirane vodne suspenzije za parenteralno uporabo SI1282402T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/571,395 US6495534B2 (en) 2000-05-15 2000-05-15 Stabilized aqueous suspensions for parenteral use
EP01945040A EP1282402B1 (en) 2000-05-15 2001-04-25 Stabilized aqueous suspensions for parenteral use
PCT/EP2001/004643 WO2001087266A1 (en) 2000-05-15 2001-04-25 Stabilized aqueous suspensions for parenteral use

Publications (1)

Publication Number Publication Date
SI1282402T1 true SI1282402T1 (sl) 2006-04-30

Family

ID=24283530

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130485T SI1282402T1 (sl) 2000-05-15 2001-04-25 Stabilizirane vodne suspenzije za parenteralno uporabo

Country Status (30)

Country Link
US (3) US6495534B2 (forum.php)
EP (1) EP1282402B1 (forum.php)
JP (1) JP4205341B2 (forum.php)
KR (1) KR100828957B1 (forum.php)
CN (1) CN100473376C (forum.php)
AR (3) AR029924A1 (forum.php)
AT (1) ATE313316T1 (forum.php)
AU (2) AU6737101A (forum.php)
BR (1) BR0110841A (forum.php)
CA (1) CA2409059C (forum.php)
CZ (1) CZ303872B6 (forum.php)
DE (1) DE60116084T2 (forum.php)
DK (1) DK1282402T3 (forum.php)
EA (1) EA007682B1 (forum.php)
EE (1) EE05376B1 (forum.php)
ES (1) ES2254443T3 (forum.php)
HK (1) HK1054194B (forum.php)
HU (1) HU229800B1 (forum.php)
IL (2) IL152537A (forum.php)
IN (1) IN224279B (forum.php)
MX (1) MXPA02011195A (forum.php)
NO (1) NO332215B1 (forum.php)
NZ (1) NZ522324A (forum.php)
PE (1) PE20011322A1 (forum.php)
PL (1) PL203075B1 (forum.php)
SI (1) SI1282402T1 (forum.php)
SK (1) SK287641B6 (forum.php)
TW (1) TWI256310B (forum.php)
WO (1) WO2001087266A1 (forum.php)
ZA (1) ZA200208738B (forum.php)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
ES2273078T3 (es) 2002-08-21 2007-05-01 Pharmacia Corporation Suspension farmaceutica inyectable en un vial con dos camaras.
US20050054716A1 (en) * 2002-11-08 2005-03-10 Gogate Uday Shankar Pharmaceutical compositions and methods of using taxane derivatives
CA2520775A1 (en) * 2003-03-31 2004-10-21 Alza Corporation Non-aqueous single phase vehicles and formulations utilizing such vehicles
WO2005020880A2 (en) * 2003-09-03 2005-03-10 Miscon Trading S.A. Methods for the treatment of endometriosis
US20050171167A1 (en) * 2003-11-04 2005-08-04 Haby Thomas A. Process and formulation containing epothilones and analogs thereof
US20050106214A1 (en) * 2003-11-14 2005-05-19 Guohua Chen Excipients in drug delivery vehicles
CA2581076A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
WO2006099121A2 (en) * 2005-03-10 2006-09-21 Elan Pharma International Limited Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070154546A1 (en) * 2005-12-30 2007-07-05 Zhang Jack Y Sustained release pharmaceutical compositions
EP1993598A2 (en) * 2006-02-15 2008-11-26 Tika Läkemedel AB Methods of manufacturing corticosteroid solutions
TW200806317A (en) * 2006-03-20 2008-02-01 Wyeth Corp Methods for reducing protein aggregation
JP5371180B2 (ja) * 2006-06-15 2013-12-18 日立コンシューマエレクトロニクス株式会社 投写型映像表示装置
US7687516B2 (en) * 2006-09-27 2010-03-30 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
EP2083823A4 (en) * 2006-09-27 2010-01-13 Eagle Pharmaceuticals Inc ALCOHOL-FREE FORMULATION OF ARGATROBAN
US20100076019A1 (en) * 2006-10-11 2010-03-25 Eagle Pharmaceuticals, Inc. Alcohol free formulation of argatroban
GB0625962D0 (en) * 2006-12-23 2007-02-07 Renovo Ltd Medicaments and methods for wound healing
WO2009026473A2 (en) * 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
US8287729B2 (en) * 2008-04-28 2012-10-16 California Polytechnic Corporation Field water purification system
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
UY33103A (es) * 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
AU2012273121B2 (en) 2011-06-19 2016-08-25 Abogen, Inc. Devices, solutions and methods for sample collection
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
UA74095U (ru) * 2012-07-20 2012-10-10 Николай Иванович Гуменюк Препарат для лечения туберкулеза
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015042163A1 (en) * 2013-09-17 2015-03-26 Terapio Corporation Methods of preventing or treating mucositis using rlip76
CN104706578B (zh) * 2013-12-14 2019-04-23 天津金耀集团有限公司 一种醋酸甲泼尼龙混悬注射液组合物的制备方法
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US9265396B1 (en) 2015-03-16 2016-02-23 Irobot Corporation Autonomous floor cleaning with removable pad
US9907449B2 (en) 2015-03-16 2018-03-06 Irobot Corporation Autonomous floor cleaning with a removable pad
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3423036B1 (en) 2016-03-02 2022-01-26 Teva Pharmaceutical Industries Ltd. Medroxyprogesterone acetate injectable compositions and methods of use
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
RU2018133932A (ru) 2016-04-01 2020-05-12 Терапьютиксмд, Инк. Фармацевтическая композиция стероидного гормона
IL285928B2 (en) * 2016-05-06 2025-06-01 Eagle Pharmaceuticals Inc Fulvestrant formulations and methods of their use
US11590077B2 (en) * 2016-05-06 2023-02-28 Eagle Pharmaceuticals, Inc. Fulvestrant formulations and methods of their use
SI3651736T1 (sl) 2017-07-14 2021-11-30 Janssen Pharmaceutica Nv Formulacije z dolgim delovanjem
EP3678637A1 (en) * 2017-09-07 2020-07-15 Teva Pharmaceutical Industries Ltd. Medroxyprogesterone acetate injectable compositions and methods of use
MX2020002606A (es) * 2017-09-07 2020-10-05 Teva Pharma Composiciones inyectables de acetato de medroxiprogesterona y metodos de uso.
AU2018366212B2 (en) * 2017-11-08 2024-06-20 Eagle Pharmaceuticals, Inc Fulvestrant formulations and methods of their use
WO2019140032A1 (en) * 2018-01-11 2019-07-18 Meritage Pharma, Inc. Stable corticosteroid compositions
AU2019334932B2 (en) 2018-09-07 2025-01-30 Family Health International D/B/A Fhi 360 Medroxyprogesterone acetate injectable compositions and methods of use
US10544923B1 (en) 2018-11-06 2020-01-28 Verifone, Inc. Devices and methods for optical-based tamper detection using variable light characteristics
KR20210118065A (ko) 2018-11-20 2021-09-29 스펙트럼 솔루션즈 엘엘씨 밀봉 캡 및 밸브를 포함하는 샘플 수집 시스템
IT201900002857A1 (it) * 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
US11701094B2 (en) 2019-06-20 2023-07-18 Spectrum Solutions L.L.C. Sample collection system including valve and plug assemblies
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
TW202239408A (zh) * 2021-01-29 2022-10-16 瑞士商艾克泰聯製藥有限公司 包含二苯基吡𠯤衍生物的醫藥組成物
US20240237929A1 (en) * 2021-05-19 2024-07-18 Acies Medical Llc Point-of-use calibration system for iron ion detection system

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
US4038389A (en) * 1975-05-07 1977-07-26 The Upjohn Company Medroxyprogesterone acetate compositions
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
JP2577744B2 (ja) 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US5208261A (en) * 1989-12-06 1993-05-04 Akzo N.V. Stabilized solutions of psychotropic agents
DK0431663T3 (da) 1989-12-06 1994-03-07 Akzo Nobel Nv Stabiliserende opløsninger af psykotrope midler
JPH0597671A (ja) 1991-10-04 1993-04-20 Sumitomo Pharmaceut Co Ltd 注射用凍結乾燥製剤
CA2120197A1 (en) 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3543144B2 (ja) 1995-03-11 2004-07-14 国際試薬株式会社 臨床検査用製剤
US5780431A (en) 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
JP2001501619A (ja) 1996-10-04 2001-02-06 アムジェン インコーポレーテッド ｍｐｌリガンドを含有する医薬組成物
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
US5880116A (en) * 1996-12-13 1999-03-09 Neurocal International Use of celastrol to treat alzheimer's disease
JP3748970B2 (ja) 1997-01-31 2006-02-22 電気化学工業株式会社 ヒアルロン酸ナトリウム含有水溶液
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
EP1017413B2 (de) 1997-09-23 2007-11-07 Rentschler Biotechnologie GmbH Flüssige interferon-beta-formulierungen
US5968918A (en) * 1997-10-17 1999-10-19 Kanda; Iwao Method for the prevention of coronary artery spasm
US5972921A (en) * 1997-12-12 1999-10-26 Hormos Medical Oy Ltd. Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
BR9909357A (pt) 1998-04-02 2000-12-12 Akzo Nobel Nv Solução ou suspensão de mirtazapina em mistura com água, formulação farmacêutica compreendendo mirtazapina, e, uso de mirtazapina
IL149008A0 (en) 1999-10-04 2002-11-10 Chiron Corp Stabilized liquid polypeptide-containing pharmaceutical compositions
US6495534B2 (en) * 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use

Also Published As

Publication number Publication date
IL165888A0 (en) 2006-01-15
KR20030020280A (ko) 2003-03-08
SK287641B6 (sk) 2011-05-06
HK1054194A1 (zh) 2003-11-21
HUP0302021A3 (en) 2011-03-28
JP2003533467A (ja) 2003-11-11
CN100473376C (zh) 2009-04-01
HK1054194B (zh) 2010-02-12
BR0110841A (pt) 2003-03-11
CA2409059C (en) 2006-04-18
EP1282402A1 (en) 2003-02-12
MXPA02011195A (es) 2003-03-10
AU6737101A (en) 2001-11-26
EA007682B1 (ru) 2006-12-29
IL152537A (en) 2007-06-17
NZ522324A (en) 2005-02-25
WO2001087266A1 (en) 2001-11-22
ATE313316T1 (de) 2006-01-15
NO20025431D0 (no) 2002-11-13
HUP0302021A2 (hu) 2003-09-29
EE05376B1 (et) 2011-02-15
AR029924A1 (es) 2003-07-23
AU2001267371B2 (en) 2006-01-05
JP4205341B2 (ja) 2009-01-07
NO332215B1 (no) 2012-07-30
US20030114430A1 (en) 2003-06-19
TWI256310B (en) 2006-06-11
DE60116084T2 (de) 2006-08-17
EE200200631A (et) 2004-04-15
ES2254443T3 (es) 2006-06-16
US6495534B2 (en) 2002-12-17
PL365793A1 (en) 2005-01-10
IN224279B (forum.php) 2005-02-25
NO20025431L (no) 2003-01-13
KR100828957B1 (ko) 2008-05-13
US20020115645A1 (en) 2002-08-22
EP1282402B1 (en) 2005-12-21
HU229800B1 (en) 2014-07-28
PE20011322A1 (es) 2002-01-10
CZ20023750A3 (cs) 2003-03-12
DE60116084D1 (de) 2006-01-26
PL203075B1 (pl) 2009-08-31
CN1429101A (zh) 2003-07-09
SK15982002A3 (sk) 2003-05-02
EA200201208A1 (ru) 2003-04-24
AR098830A2 (es) 2016-06-15
CA2409059A1 (en) 2001-11-22
CZ303872B6 (cs) 2013-06-05
ZA200208738B (en) 2003-10-29
DK1282402T3 (da) 2006-05-08
IL152537A0 (en) 2003-05-29
AR111695A2 (es) 2019-08-07
US20030130245A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AU6737101A (en) Stabilized aqueous suspensions for parenteral use
IL153754A0 (en) Pyrimidine derivatives
AU6053701A (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
AU143419S (en) Printer
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
AU143418S (en) Printer
HUP0300562A3 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the
AU2792102A (en) Pyrimidine derivatives
GB2371332B (en) Independent suspension
PL356642A1 (en) Aminomethyl-phenyl-cyclohexanone derivatives
GB0003575D0 (en) Holder
TW595555U (en) Suspension
GB2360983B (en) Vehicle suspensions
GB2359527B (en) Vehicle suspensions
AU143639S (en) Holder
GB0006351D0 (en) Vehicle suspensions
PL342463A1 (en) Aqueous filter
TW444660U (en) Suspension clip
CA93294S (en) Paper holder
GB0004490D0 (en) Vehicle suspensions
CA90959S (en) Notepad holder
SI1303496T1 (sl) Pirimidinski derivati
GB0021639D0 (en) Maurotoxin derivatives